With help from UCLA, teenage cancer patient begins to make strides
September 14, 2011 By Kim Irwin in Cancer
Allie Newman
The doctors told Allie Newman that the pain in her right thigh was tendonitis, nothing to worry about. A little physical therapy and she'd be as good as new.
Just months later, in January 2011, the 16-year-old avid skier and soccer player was diagnosed with an aggressive osteosarcoma in her thigh bone.
Her dad, Bob Newman, broke the news to his only daughter as she lay on her bed doing homework, just like she did on any other regular night. Tonight, though, everything would change.
"Just a few days before, she was skiing on a family trip and playing soccer, and now I had to sit and explain a cancer diagnosis to her," Newman said. "I ran the gamut of emotions from shock to surprise to disbelief and anger."
Cancer? At 16? She'd just gotten her driver's license and was halfway through her junior year in high school. How could this be happening?
It was an awful lot for a teenager, even one as smart and independent as Allie, to take in.
"I started crying immediately," Allie said. "I remember not knowing what was going to happen to me. I didn't really know what it meant. But my dad told me it was serious and something we had to deal with and face straight on. There was no running away."
Still reeling, Allie soon learned that she must undergo a grueling chemotherapy regimen that called for a three- to five-day hospitalization, followed by an extensive surgery that would probably result in the removal of part or all of her thigh bone, with four more months of harsh chemo afterward. She couldn't attend Brentwood High School with her friends and would be hospitalized periodically when her severely depleted immune system failed to protect her from infection. Visitors weren't possible because any germ could potentially be deadly.
Osteosarcoma is the most common bone malignancy in children, although only about 450 cases are diagnosed each year, said Dr. Noah Federman, Allie's oncologist and a researcher at UCLA's Jonsson Comprehensive Cancer Center. Allie's cancer was Stage IIb, meaning her cancer was extensive and aggressive but had not yet spread to other organs.
"That was vital, because the most important factor in terms of her prognosis was whether or not her cancer had spread," Federman said. "In Allie's case we decided to give her chemotherapy up front, hoping to kill most of the cancer before her surgery."
In the early 1970s, before oncologists started treating osteosarcomas with chemotherapy, patients with that malignancy had their limbs amputated as the conventional treatment. And 80 to 90 percent of patients died within several years when the cancer returned, usually in their lungs. Now, about 70 percent of osteosarcoma patients are long-term survivors.
Because Allie's cancer was so aggressive and still contained to her thigh bone, Federman and UCLA surgeon Dr. Jeffrey Eckardt decided to hit it with everything they had to protect her from recurrence. She has suffered many side effects, including severe nausea and hair loss, but is handling well the high doses of methotrexate, a drug that can harm organ function.
"I think she's doing great and is going to do great," Federman said. "It was tough for her. She had just gotten her driver's license and was starting to assert her independence and we took that away from her, putting her through all this therapy. For adolescents, something like this is incredibly difficult, being faced with their mortality for the first time. But she is strong and has taken this adversity and turned it into something that has benefited her. She's a really special person."
Her dad agrees.
"Allie has developed a resolve and inner strength that is amazing to see," he said. "Unquestionably this journey has changed all of us. We've learned how to lean on each other and there are times when we lean on Allie for support as much as she leans on us. She has the ability to lift our spirits and the spirits of others around her as much as we lift her up."
It's true that Allie's life has changed radically. She left school in January shortly after her diagnosis and won't be returning until next January, halfway through her senior year. She has kept up with her studies through email and online resources, a tough task for something who is hospitalized at least once a month for up to a week, and then feels pretty lousy the next week or so. But she did it, and she'll graduate with her class next June.
The first four months of her chemotherapy, prior to surgery, were brutal.
"Every side effect there was, I had," she said. "It was really hard on me. I was throwing up every single day. I was on pain killers, nausea medications. It was kind of a guessing game about how to balance it all out. But we finally figured it out."
Then came her surgery in April. When Eckardt went in, the cancer was still there 85 percent of it had been killed, but that 15 percent still living was not troublesome. Eckardt removed Allie's thigh bone and replaced it with titanium. To support to titanium rod, Allie underwent a complete hip and knee replacement. The new hip, thigh and knee assembly were drilled to her shin bone for support. And because there was still living cancer, Allie faces more chemotherapy until the end of November, with two additional drugs added to the conventional three drug chemo cocktail.
Following surgery, Allie was hospitalized for three weeks. Once she was able to get out of bed, she had to wear a body brace that reached from her waist down to her right ankle until early July. Allie is now in the midst of intensive physical therapy and has graduated from a walker to crutches. By December, she hopes to be walking with just a cane.
The girl who once skied and played soccer and lacrosse and swam and dove competitively has been told she might never run again. And although that's more than enough to turn any teenager into a blubbering mess or a sulky recluse, Allie has remained positive.
And she keeps surprising her doctors, too. She was walking a week before predicted and plans to be able to walk down the street "just like anyone else" by next year. Every free moment is used working her right leg, making it stronger.
"At first it was really hard, being in the hospital and being really sick and not being able to see my friends. I'd see on Facebook that my friends were taking trips and going to parties and it was difficult," Allie said. "I got into a deep hole, but after surgery I popped out of it. I have a long way to go still and I have to fight this."
Along the way, Allie has discovered that her cancer diagnosis might not be all bad.
"It's not that I feel lucky to be diagnosed with cancer, but considering everything, I'm pretty lucky," said Allie, now 17. "A lot of people in my position lose their legs. Really, this is just 12 months of my life, a bump in the road. There is light at the end of my tunnel. I get to go back to my normal life. What I've learned through this has been pretty amazing."
Right now, Allie thinks in terms of getting through each day, each week. The future is out there waiting, but it's the present she's focused on. She recently felt well enough to take a quick trip to San Diego and sat by the pool and visited Sea World. It was just so nice, she said, to "feel normal."
She has decided to take a gap year after graduation because she missed all the crucial college prep that takes place junior year. And she's considering a career in medicine
"I do imagine going back to school and what the first day of class will be like," Allie said. "It will be so strange to see everyone again and be sitting in a classroom. This has been a life-changing experience and I've gotten so much support. People I don't know come up to me and tell me they're praying for me. That's pretty amazing."
Provided by
University of California Los Angeles
-
Scientists create new cell lines from ocular melanoma patients
Mar 11, 2011 |
not rated yet |
0
-
Majority of Americans think they pay more toward social security and medicare than they do
Jun 29, 2011 |
not rated yet |
0
-
Hot, Humid Weather Could Affect Asthma Sufferers
Jul 21, 2011 |
not rated yet |
0
-
New imaging technology predicts fracture risk
Oct 27, 2010 |
not rated yet |
0
-
Losing weight, keeping it off might require distinct skill sets
Jul 05, 2011 |
not rated yet |
0
-
Of mice and mental models: Neuroscientific implications of risk-optimized behavior in the mouse
22 hours ago |
not rated yet |
0
-
Limits to growth: Scientists identify key metastasis-enabling enzyme
May 22, 2012 |
5 / 5 (4) |
0
-
Seeing is as seeing does: Spatially-structured retinal input in early development of cortical maps
Apr 26, 2012 |
5 / 5 (4) |
1
-
Dreamless nights: Brain activity during nonrapid eye movement sleep
Apr 09, 2012 |
4.4 / 5 (12) |
0
-
Take your time: Neurobiology sheds light on the superiority of spaced vs. massed learning
Mar 28, 2012 |
4.5 / 5 (21) |
3
-
A question about drug tolerance
May 23, 2012
-
Poor nutrition leading to overeating?
May 23, 2012
-
Math and dyslexia?
May 21, 2012
-
portable metabolism meter?
May 21, 2012
-
Rare medical conditions on 20/20 tonight
May 18, 2012
-
"Good" Cholesterol in Doubt
May 17, 2012
- More from Physics Forums - Medical Sciences
More news stories
Skp2 activates cancer-promoting, glucose-processing Akt
HER2 and its epidermal growth factor receptor cousins mobilize a specialized protein to activate a major player in cancer development and sugar metabolism, scientists report in the May 25 issue of Cell.
Cancer
16 hours ago |
not rated yet |
0
|
Pancreatectomy OK without downstaging from therapy
(HealthDay) -- Pancreatectomy improves median survival in pancreatic cancer patients even when presurgical neoadjuvant therapy does not lead to radiographic downstaging of tumors, according to a study published ...
Cancer
17 hours ago |
not rated yet |
0
Common therapies for basal cell carcinoma offer similar survival
(HealthDay) -- For patients with superficial basal cell carcinoma (sBCC), treatment with imiquimod or photodynamic therapy (PDT) results in similar long-term tumor-free survival, according to a review published ...
Cancer
17 hours ago |
not rated yet |
0
Cancer may require simpler genetic mutations than previously thought
Chromosomal deletions in DNA often involve just one of two gene copies inherited from either parent. But scientists haven't known how a deletion in one gene from one parent, called a "hemizygous" deletion, can contribute ...
Cancer
20 hours ago |
not rated yet |
0
|
New prostate cancer screening guidelines face a tough sell, study suggests
(Medical Xpress) -- Recent recommendations from the U.S. Preventive Services Task Force (USPSTF) advising elimination of routine prostate-specific antigen (PSA) screening for prostate cancer in healthy men are likely to encounter ...
Cancer
22 hours ago |
not rated yet |
1
Of mice and mental models: Neuroscientific implications of risk-optimized behavior in the mouse
(Medical Xpress) -- Regardless of an organism’s biological complexity, every encephalized animal continuously makes under-informed behavioral choices that can have serious consequences. Despite its ubiquity, ...
Tongue analysis software uses ancient Chinese medicine to warn of disease
For 5,000 years, the Chinese have used a system of medicine based on the flow and balance of positive and negative energies in the body. In this system, the appearance of the tongue is one of the measures used to classify ...
Inherited DNA change explains overactive leukemia gene
A small inherited change in DNA is largely responsible for overactivating a gene linked to poor treatment response in people with acute leukemia.
Early physical therapist treatment associated with reduced risk of healthcare utilization and reduced overall healthcare
A new study published in Spine shows that early treatment by a physical therapist for low back pain (LBP), as compared to delayed treatment, was associated with reduced risk of subsequent healthcare utilization and lower ...
New device allows pacemaker patients to safely undergo MRIs
For many, it's a medical conundrum: The very pacemaker keeping their heart in rhythm prevents them from undergoing an MRI to diagnose other ailments, because interaction between the two devices could prove deadly.
First study to suggest that the immune system may protect against Alzheimer's changes in humans
Recent work in mice suggested that the immune system is involved in removing beta-amyloid, the main Alzheimer's-causing substance in the brain. Researchers have now shown for the first time that this may apply in humans.